➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Baxter
Harvard Business School
Mallinckrodt
Boehringer Ingelheim
McKinsey
Colorcon

Last Updated: August 3, 2020

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: CEFTAZIDIME

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

CEFTAZIDIME

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Acs Dobfar CEFTAZIDIME ceftazidime INJECTABLE;INJECTION 062640 ANDA Sagent Pharmaceuticals 25021-127-20 25 VIAL in 1 CARTON (25021-127-20) > 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL
Acs Dobfar CEFTAZIDIME ceftazidime INJECTABLE;INJECTION 062640 ANDA Sagent Pharmaceuticals 25021-127-66 25 VIAL in 1 CARTON (25021-127-66) > 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL
Acs Dobfar CEFTAZIDIME ceftazidime INJECTABLE;INJECTION 062640 ANDA Sagent Pharmaceuticals 25021-128-50 10 VIAL in 1 CARTON (25021-128-50) > 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Moodys
Dow
Merck
Colorcon
Boehringer Ingelheim